Different Safety Pattern of an Inactivated SARS-CoV-2 Vaccine (CoronaVac(®)) According to Age Group in a Pediatric Population from 3 to 17 Years Old, in an Open-Label Study in Chile

During the COVID-19 pandemic, the importance of vaccinating children against SARS-CoV-2 was rapidly established. This study describes the safety of CoronaVac(®) in children and adolescents between 3- and 17-years-old in a multicenter study in Chile with two vaccine doses in a 4-week interval. For al...

Descripción completa

Detalles Bibliográficos
Autores principales: Le Corre, Nicole, Abarca, Katia, Astudillo, Patricio, Potin, Marcela, López, Sofía, Goldsack, Macarena, Valenzuela, Vania, Schilling, Andrea, Gaete, Victoria, Rubio, Lilian, Calvo, Mario, Twele, Loreto, González, Marcela, Fuentes, Daniela, Gutiérrez, Valentina, Reyes, Felipe, Tapia, Lorena I., Villena, Rodolfo, Retamal-Díaz, Angello, Cárdenas, Antonio, Alarcón-Bustamante, Eduardo, Meng, Xing, Xin, Qianqian, González-Aramundiz, José V., Álvarez-Figueroa, María Javiera, González, Pablo A., Bueno, Susan M., Soto, Jorge A., Perret, Cecilia, Kalergis, Alexis M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611329/
https://www.ncbi.nlm.nih.gov/pubmed/37896930
http://dx.doi.org/10.3390/vaccines11101526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611329/
https://www.ncbi.nlm.nih.gov/pubmed/37896930
http://dx.doi.org/10.3390/vaccines11101526

Ejemplares similares